Bronchoscopy Market - By Product Type (Rigid Bronchoscopes, Flexible Bronchoscopes), By Product Usage (Single Use/ Disposable, Reusable), By Age Group (Adult, Pediatric) – Global Forecast, 2023-2032

Bronchoscopy Market Size

Bronchoscopy Market size was valued at USD 2.8 billion in 2022 and is estimated to account for USD 6 billion by 2032. Bronchoscopy is the most common interventional pulmonology technique performed using a bronchoscope. It can be carried out using either single-use or reusable bronchoscopes.
 

According to WHO, chronic obstructive pulmonary disease (COPD) is one of the leading causes of death globally, with nearly 3.23 million casualties reported in 2019. Therefore, the growing chronic respiratory disease burden highlights the significance of bronchoscopy as a crucial treatment, making it significant driver for the market progress.
 

Moreover, as healthcare systems and individuals become more aware of the importance of early detection and screening for lung cancer, the demand for bronchoscopy procedures have increased considerably. Patients and healthcare providers are increasingly turning to bronchoscopy as a valuable tool for diagnosing lung cancer in its early and more treatable stages.
 

COVID-19 Impact

The COVID-19 pandemic had a positive impact on the bronchoscopy market with upsurge in product demand owing to the substantial patient base suffering from acute respiratory syndrome. For instance, in April 2021, bronchoscopy enabled the removal of mucus plugs, intrabronchial obstructions as well as the resolution of atelectasis in critically ill patients with COVID-19. This enabled mechanical ventilation among these patients. Thus, the rapidly growing COVID-19 cases globally positively influenced the demand for bronchoscopy.
 

Bronchoscopy Market Trends

Bronchoscopy is considered as a minimally invasive procedure. Several benefits associated with minimally invasive procedures include rapid recovery, effective management of post-surgical pain, reduced surgical complications and shorter stay in the hospitals, accelerating the demand for minimally invasive procedure in coming years, thereby positively impacting the industry landscape.
 

• Furthermore, as awareness regarding the effectiveness and benefits associated with bronchoscopy procedures rises among healthcare professionals and the public, there will be a growing demand for this treatment.
   
• As the elderly population base expands, there is a greater need for bronchoscopy procedures for both diagnosis and treatment.
   

Bronchoscopy Market Analysis

The market by product type is categorized into rigid bronchoscopes, flexible bronchoscopes, and others. The flexible bronchoscopes segment garnered USD 1.6 billion revenue size in the year 2022.

• The dominance of the segment is attributed to rising prevalence of respiratory disorders, including lung cancer, chronic obstructive pulmonary disease (COPD), asthma, etc. driving the demand for flexible bronchoscopy procedures as a primary method for respiratory diseases testing and treatment.
   
• Additionally, multiple advantages including fast recovery time post flexible bronchoscopy as compared to rigid one coupled with being cost-effective is further projected to augment the market size.
   

Based on product usage, the bronchoscopy market is segmented into single-use/ disposable and reusable. The single-use/disposable segment accounted for over 43% business share in the year 2022.
 

• Single-use bronchoscopes are ready for use, reducing preparation time and streamlining procedures. This convenience is especially valuable in emergency and critical care settings.
   
• Further, significant advantages associated with use of disposable bronchoscopes include ease of compliance with cleaning and disinfection regulations during non-working hours, minimizing costs associated to trauma repairs during use.
   

The bronchoscopy market by age group is categorized into adult and pediatric. The adult segment garnered USD 2.4 billion revenue size in the year 2022.
 

• In adults, bronchoscopy is most often used to take samples of suspicious lesions as well as for culturing specific areas in the lungs. Flexible bronchoscopy is majorly used to treat non-resolving lungs abscess, pneumonia, atelectasis, and other diseases among adults.
   
• Additionally, growing prevalence of asthma and other respiratory diseases in adults along with accessibility to different size of bronchoscopes will further contribute to the segment expansion.
   

U.S. bronchoscopy market accounted for USD 840 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The U.S. has taken a commanding position in the market, primarily due to increasing consumption of tobacco and smoking that led to several respiratory diseases. Therefore, increasing prevalence of respiratory diseases is anticipated to boost the demand for bronchoscopy.
   
• Additionally, the elderly population base is more susceptible to respiratory disorders such pulmonary hypertension, asthma, and COPD which will further stimulate the demand for therapeutic respiratory devices, worth USD 47 billion in 2022, thereby accelerating market trends.
   

Bronchoscopy Market Share

The bronchoscopy industry is consolidated, with key players such as Boston Scientific, and few others dominating the market. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in August 2021, Boston Scientific Corporation received the U.S. FDA approval for its single-use bronchoscope EXALT MODEL B. designed to be used in bedside procedures within the operating room (OR) and intensive care unit (ICU). Therefore, introduction of such products helps the company in strengthening its product portfolio coupled with sustaining its market position.
 

Some of the eminent market participants operating in the bronchoscopy industry include:

• Hoya Corporation
• Conmed Corporation
• Teleflex Incorporated
• Boston Scientific Corporation
• Medtronic plc
• Ambu A/S
• Auris Health (Johnson & Johnson)
• Verathon Inc.
• Cook Medical Inc.
• Richard Wolf GmbH
• Broncus Medical Inc
• Olympus Corporation
• Karl Storz GmbH & Co. KG
• FUJIFILM Holdings America Corporation
• Cogentix Medical.
   

Bronchoscopy Industry News:

• In July 2022, Ambu Inc. announced regulatory clearance from the U.S. FDA for its single-use, sterile bronchoscopes Ambu aScopeTM 5 Broncho. This strategic move helped the company to expand its product offerings and gain significant market share in this business space.
   
• In July 2022, Verathon introduced single-use bronchoscope BFlex 2.8. This bronchoscope is primarily used in critical needs of the operating room, ICU, and emergency department. Therefore, such product launches are anticipated to augment industry expansion.
   

Bronchoscopy market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Product Type, 2018-2032 (USD Million)

• Rigid bronchoscopes
• Flexible bronchoscopes
• Other product types

By Product Usage, 2018-2032 (USD Million)

• Single use/disposable
• Reusable

By Age Group, 2018-2032 (USD Million)

• Adult
• Pediatric

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa